{"data":{"id":"us/45-cfr-182.20","jurisdiction":"us","citation":"45 CFR 182.20","heading":"Definitions.","body":"The following definitions and abbreviated terms apply to this part:\nCash price means the charge that applies to an individual who pays cash (or cash equivalent) for a COVID-19 diagnostic test.\nCOVID-19 for purposes of this part is the abbreviated term for the virus called SARS-CoV-2 and the disease it causes, called coronavirus disease 2019.\nDiagnostic test for COVID-19 (“COVID-19 diagnostic test”) means a COVID-19 in vitro diagnostic test described in section 6001 of the Families First Coronavirus Response Act (Pub. L. 116-127, March 18, 2020), as amended by section 3201 of the CARES Act (Pub. L. 116-136, March 27, 2020).\nProvider of a diagnostic test for COVID-19 (“provider”) means any facility that performs one or more COVID-19 diagnostic tests.","path":["Title 45—Public Welfare","SUBTITLE A—Department of Health and Human Services","SUBCHAPTER E—PRICE TRANSPARENCY","PART 182—PRICE TRANSPARENCY FOR COVID-19 DIAGNOSTIC TESTS","Subpart A—General Provisions"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-45.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:26:21Z","sha256":"0c80121b57517b310a0cd1b813f8e47e7ec5ed369508a146636ac7f56f9b818d","source_id":"us-cfr","stale":true,"prev":"us/45-cfr-182.10","next":"us/45-cfr-182.30"},"notice":"GroundRules: Original legal text. Not legal advice."}